New therapy for severe refractory gout

9 November 2008 Print this article Comments Share this article
Pelgloticase effectively reduces serum urate and relieves pain in patients with severe-refractory gout, according to phase III studies presented at the annual symposium of the American College of Rheumatology....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites